These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6807391

  • 1. Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.
    Barrett AJ, Kendra JR, Lucas CF, Joss DV, Joshi R, Pendharkar P, Hugh-Jones K.
    Br Med J (Clin Res Ed); 1982 Jul 17; 285(6336):162-6. PubMed ID: 6807391
    [Abstract] [Full Text] [Related]

  • 2. A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
    Stockschlaeder M, Storb R, Pepe M, Longton G, McDonald G, Anasetti C, Appelbaum F, Doney K, Martin P, Sullivan K.
    Br J Haematol; 1992 Jan 17; 80(1):49-54. PubMed ID: 1536809
    [Abstract] [Full Text] [Related]

  • 3. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
    Storb R, Deeg HJ, Pepe M, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J.
    Br J Haematol; 1989 Aug 17; 72(4):567-72. PubMed ID: 2673331
    [Abstract] [Full Text] [Related]

  • 4. Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host disease.
    Harper JI, Kendra JR, Desai S, Staughton RC, Barrett AJ, Hobbs JR.
    Br J Dermatol; 1984 Apr 17; 110(4):469-74. PubMed ID: 6370294
    [Abstract] [Full Text] [Related]

  • 5. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
    Mrsić M, Labar B, Bogdanić V, Nemet D, Pavletić Z, Plavsić F, Dobrić I, Marusić M, Francetić I, Kastelan A.
    Bone Marrow Transplant; 1990 Aug 17; 6(2):137-41. PubMed ID: 2207450
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.
    Truog AW, Wozniak SP.
    Oncol Nurs Forum; 1990 Aug 17; 17(1):39-44. PubMed ID: 2405360
    [Abstract] [Full Text] [Related]

  • 7. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K, Downs K, Ashby M, Dodds A, Concannon A, Biggs J.
    Bone Marrow Transplant; 1989 Jan 17; 4(1):23-7. PubMed ID: 2647183
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporin A and chronic graft versus host disease.
    Bacigalupo A, Maiolino A, Van Lint MT, Occhini D, Gualandi F, Clavio M, Lamparelli T, Tong J, Marmon AM.
    Bone Marrow Transplant; 1990 Nov 17; 6(5):341-4. PubMed ID: 2291996
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
    Bacigalupo A, Frassoni F, van Lint MT, Raffo MR, Vitale V, Corbetta G, Chierichetti S, Marmont AM.
    Exp Hematol; 1985 May 17; 13(4):244-8. PubMed ID: 3886417
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease.
    Shepherd JD, Shore TB, Reece DE, Barnett MJ, Klingemann HG, Buskard NA, Phillips GL.
    Bone Marrow Transplant; 1988 Nov 17; 3(6):553-8. PubMed ID: 3063323
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.
    Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HE, Lawson D, McElwain TJ, Alexander P.
    Lancet; 1980 Feb 16; 1(8164):327-9. PubMed ID: 6101787
    [Abstract] [Full Text] [Related]

  • 12. [Cyclosporin in allogeneic bone marrow transplantation].
    Klingemann HG, Storb R.
    Internist (Berl); 1985 Sep 16; 26(9):569-74. PubMed ID: 3905679
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.
    Aschan J, Ringdén O, Sundberg B, Gahrton G, Ljungman P, Winiarski J.
    Bone Marrow Transplant; 1991 Feb 16; 7(2):113-9. PubMed ID: 2049554
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Bone marrow transplantation in leukemia and aplastic anemia].
    Speck B, Gratwohl A, Nissen C, Osterwalder B, Signer E, Jeannet M.
    Schweiz Med Wochenschr; 1983 Apr 30; 113(17):622-9. PubMed ID: 6346483
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.